Pricing

OREXIGEN THERAPEUTICS, INC.

0 followers ·
SAN DIEGO CA
Orexigen Therapeutics is based out of San Diego. Orexigen Therapeutics, Inc. operates as a biopharmaceutical company focusing on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. Its lead combination product candidates targeted for obesity are Contrave, which is in Phase III clinical trials, and Empatic, which is in the later stages of Phase II development. These two product candidates are designed based on the company's understanding of how the brain appears to regulate appetite and energy expenditure, as well as the mechanisms that come into play to limit weight loss over time. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss.Whalewisdom has at least 211 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2017-03-03. The notice included securities offered of Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

Contact information is taken directly from publicly disclosed SEC filings.

OREXIGEN THERAPEUTICS, INC.
12481 HIGH BLUFF DRIVE, SUITE 160
SAN DIEGO CA    92130

Business Phone: (858) 436-8600
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Filing Date
SC 13D/A 2019-06-04
4 2019-06-04
15-12B 2019-05-31
8-K 2019-05-23
8-K 2019-05-03
CT ORDER 2019-04-26
8-K 2019-04-02
8-K 2019-03-04
SC 13G/A 2019-02-14
SC 13G/A 2019-02-14